![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ETFA |
Gene summary for ETFA |
![]() |
Gene information | Species | Human | Gene symbol | ETFA | Gene ID | 2108 |
Gene name | electron transfer flavoprotein subunit alpha | |
Gene Alias | EMA | |
Cytomap | 15q24.2-q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006082 | UniProtAcc | A0A0S2Z3L0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2108 | ETFA | C57 | Human | Oral cavity | OSCC | 5.15e-17 | 8.10e-01 | 0.1679 |
2108 | ETFA | C06 | Human | Oral cavity | OSCC | 3.35e-07 | 1.26e+00 | 0.2699 |
2108 | ETFA | C07 | Human | Oral cavity | OSCC | 3.69e-04 | 1.31e+00 | 0.2491 |
2108 | ETFA | C08 | Human | Oral cavity | OSCC | 3.34e-42 | 1.11e+00 | 0.1919 |
2108 | ETFA | C09 | Human | Oral cavity | OSCC | 2.55e-03 | 3.11e-01 | 0.1431 |
2108 | ETFA | LN22 | Human | Oral cavity | OSCC | 1.21e-20 | 2.03e+00 | 0.1733 |
2108 | ETFA | LN46 | Human | Oral cavity | OSCC | 3.07e-14 | 8.80e-01 | 0.1666 |
2108 | ETFA | LP15 | Human | Oral cavity | LP | 1.37e-14 | 2.16e+00 | 0.2174 |
2108 | ETFA | LP17 | Human | Oral cavity | LP | 1.64e-05 | 1.12e+00 | 0.2349 |
2108 | ETFA | SYSMH1 | Human | Oral cavity | OSCC | 3.36e-08 | 4.57e-01 | 0.1127 |
2108 | ETFA | SYSMH2 | Human | Oral cavity | OSCC | 1.93e-23 | 1.04e+00 | 0.2326 |
2108 | ETFA | SYSMH3 | Human | Oral cavity | OSCC | 1.07e-26 | 1.11e+00 | 0.2442 |
2108 | ETFA | SYSMH4 | Human | Oral cavity | OSCC | 8.12e-08 | 2.69e-01 | 0.1226 |
2108 | ETFA | P4_S8_cSCC | Human | Skin | cSCC | 2.07e-06 | 1.57e-01 | -0.3095 |
2108 | ETFA | P5_S10_cSCC | Human | Skin | cSCC | 1.84e-06 | 5.41e-02 | -0.299 |
2108 | ETFA | P1_cSCC | Human | Skin | cSCC | 8.47e-48 | 1.58e+00 | 0.0292 |
2108 | ETFA | P2_cSCC | Human | Skin | cSCC | 1.78e-20 | 8.11e-01 | -0.024 |
2108 | ETFA | P4_cSCC | Human | Skin | cSCC | 2.00e-52 | 1.39e+00 | -0.00290000000000005 |
2108 | ETFA | P10_cSCC | Human | Skin | cSCC | 9.29e-42 | 1.53e+00 | 0.1017 |
2108 | ETFA | cSCC_p8 | Human | Skin | cSCC | 6.43e-06 | 1.52e-01 | -0.1971 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006091 | Colorectum | AD | generation of precursor metabolites and energy | 209/3918 | 490/18723 | 3.17e-28 | 6.61e-25 | 209 |
GO:0022900 | Colorectum | AD | electron transport chain | 89/3918 | 175/18723 | 1.42e-18 | 8.91e-16 | 89 |
GO:0044282 | Colorectum | AD | small molecule catabolic process | 118/3918 | 376/18723 | 1.05e-06 | 3.55e-05 | 118 |
GO:0006635 | Colorectum | AD | fatty acid beta-oxidation | 33/3918 | 74/18723 | 3.98e-06 | 1.09e-04 | 33 |
GO:0009062 | Colorectum | AD | fatty acid catabolic process | 41/3918 | 100/18723 | 4.02e-06 | 1.09e-04 | 41 |
GO:0019395 | Colorectum | AD | fatty acid oxidation | 40/3918 | 103/18723 | 2.43e-05 | 4.69e-04 | 40 |
GO:0016042 | Colorectum | AD | lipid catabolic process | 97/3918 | 320/18723 | 4.31e-05 | 7.56e-04 | 97 |
GO:0006631 | Colorectum | AD | fatty acid metabolic process | 114/3918 | 390/18723 | 5.58e-05 | 9.44e-04 | 114 |
GO:0072329 | Colorectum | AD | monocarboxylic acid catabolic process | 44/3918 | 122/18723 | 8.05e-05 | 1.28e-03 | 44 |
GO:0034440 | Colorectum | AD | lipid oxidation | 40/3918 | 108/18723 | 8.52e-05 | 1.32e-03 | 40 |
GO:0030258 | Colorectum | AD | lipid modification | 67/3918 | 212/18723 | 1.66e-04 | 2.27e-03 | 67 |
GO:0016054 | Colorectum | AD | organic acid catabolic process | 73/3918 | 240/18723 | 3.20e-04 | 3.81e-03 | 73 |
GO:0044242 | Colorectum | AD | cellular lipid catabolic process | 66/3918 | 214/18723 | 3.96e-04 | 4.50e-03 | 66 |
GO:0046395 | Colorectum | AD | carboxylic acid catabolic process | 70/3918 | 236/18723 | 9.06e-04 | 8.71e-03 | 70 |
GO:00060912 | Colorectum | MSS | generation of precursor metabolites and energy | 186/3467 | 490/18723 | 1.14e-24 | 2.15e-21 | 186 |
GO:00229002 | Colorectum | MSS | electron transport chain | 83/3467 | 175/18723 | 2.06e-18 | 1.17e-15 | 83 |
GO:00090622 | Colorectum | MSS | fatty acid catabolic process | 32/3467 | 100/18723 | 8.28e-04 | 8.67e-03 | 32 |
GO:00442822 | Colorectum | MSS | small molecule catabolic process | 94/3467 | 376/18723 | 9.85e-04 | 9.86e-03 | 94 |
GO:00302582 | Colorectum | MSS | lipid modification | 57/3467 | 212/18723 | 1.64e-03 | 1.49e-02 | 57 |
GO:00066312 | Colorectum | MSS | fatty acid metabolic process | 95/3467 | 390/18723 | 2.20e-03 | 1.84e-02 | 95 |
Page: 1 2 3 4 5 6 7 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ETFA | SNV | Missense_Mutation | c.626G>A | p.Arg209Gln | p.R209Q | P13804 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ETFA | SNV | Missense_Mutation | c.196G>T | p.Asp66Tyr | p.D66Y | P13804 | protein_coding | deleterious(0.02) | possibly_damaging(0.641) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
ETFA | SNV | Missense_Mutation | c.626N>A | p.Arg209Gln | p.R209Q | P13804 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AA-A02W-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ETFA | SNV | Missense_Mutation | c.280N>G | p.Pro94Ala | p.P94A | P13804 | protein_coding | tolerated(0.19) | benign(0.309) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
ETFA | SNV | Missense_Mutation | novel | c.893N>T | p.Ala298Val | p.A298V | P13804 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ETFA | SNV | Missense_Mutation | c.196N>T | p.Asp66Tyr | p.D66Y | P13804 | protein_coding | deleterious(0.02) | possibly_damaging(0.641) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ETFA | SNV | Missense_Mutation | c.986T>C | p.Ile329Thr | p.I329T | P13804 | protein_coding | tolerated(0.45) | benign(0) | TCGA-A5-A0GP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ETFA | SNV | Missense_Mutation | novel | c.983A>C | p.Glu328Ala | p.E328A | P13804 | protein_coding | tolerated(0.24) | benign(0.001) | TCGA-A5-A1OH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | CR |
ETFA | SNV | Missense_Mutation | novel | c.483G>T | p.Glu161Asp | p.E161D | P13804 | protein_coding | tolerated(1) | benign(0.007) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ETFA | SNV | Missense_Mutation | rs865839624 | c.137G>A | p.Arg46His | p.R46H | P13804 | protein_coding | deleterious(0.05) | benign(0.001) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |